Web5 apr. 2024 · Jiangsu Vcare Pharmatech: Trk inhibitor: Ph1/2 trial in locally advanced/metastatic solid tumours ongoing in China; could report 2024: PBI-200: Pyramid Biosciences: Trk inhibitor: Ph1/2 trial in advanced or metastatic tumours, including CNS tumours, could report 2024: FCN-011: Fosun International: Trk A, B and C inhibitor WebJiangsu Vcare Pharmatech is a biotech pharmaceutical company that develops drug intermediates, active pharmaceutical ingredients and related substances, and fine …
江苏威凯尔医药科技有限公司
WebDiscovery Company profile page for Jiangsu Vcare PharmaTech Co., Ltd. including technical research,competitor monitor,market trends,company profile& stock symbol WebDiscovery Company profile page for Jiangsu Vcare PharmaTech Co., Ltd. including technical research,competitor monitor,market trends,company profile& stock symbol family link schoolmaster
products_Jiangsu Vcare PharmaTech Co. Ltd.,
WebJiangsu Vcare PharmaTech Co. Ltd., located in Nanjing Jiangbei New Area, one of state-level new areas, is a high-tech company providing research and development services … Webproducts-Jiangsu Vcare PharmaTech Co. Ltd.,-Jiangsu Vcare PharmaTech Co. Ltd., located in Nanjing Jiangbei New Area, one of state-level new areas, is a high-tech … WebJiangsu Vcare PharmaTech Co. Ltd., located in Nanjing Jiangbei New Area, one of state-level new areas, is a high-tech company providing research and development services … family links course